Calutide 50mg Tablets

Bicalutamide belongs to a class of medications known as anti-androgens, which work by blocking androgen receptors on prostate cancer cells, preventing testosterone and other male hormones from binding to and stimulating cancer cell growth. Since prostate cancer cells often rely on these hormones to grow and multiply, blocking their effects helps slow disease progression and can support better disease management. It is commonly used in combination with other hormone therapies, such as GnRH agonists, as part of a treatment approach known as combined androgen blockade, providing more comprehensive hormonal control of the cancer. Bicalutamide is often used in the treatment of advanced or metastatic prostate cancer, helping manage the disease as part of a broader, individualized treatment plan. The medication is taken orally, usually once daily, making it a convenient addition to a combination hormone therapy regimen. Regular monitoring, including prostate-specific antigen (PSA) level checks, is an important part of treatment to help track the body's response and guide any necessary adjustments. Many patients experience effective disease control and symptom management with consistent use of Bicalutamide as part of their treatment plan. Ongoing follow-up with an oncologist or urologist helps ensure the treatment remains appropriate and effective over time. As with all hormone therapies for prostate cancer, Bicalutamide should be used under the close supervision of a healthcare provider experienced in prostate cancer care.